b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29019117</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>07</Month>\n            <Day>12</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>12</Month>\n            <Day>02</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1550-7416</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>19</Volume>\n                    <Issue>6</Issue>\n                    <PubDate>\n                        <Year>2017</Year>\n                        <Month>11</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>The AAPS journal</Title>\n                <ISOAbbreviation>AAPS J</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Clearance and Liver Partitioning of OATP and OCT Substrates in Cynomolgus Monkeys.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>1878-1889</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1208/s12248-017-0151-z</ELocationID>\n            <Abstract>\n                <AbstractText>In the present investigations, we evaluate in vitro hepatocyte uptake and partitioning for the prediction of in vivo clearance and liver partitioning. Monkeys were intravenously co-dosed with rosuvastatin and bosentan, substrates of the organic anion transporting polypeptides (OATPs), and metformin, a substrate of organic cation transporter 1 (OCT1). Serial plasma and liver samples were collected over time. Liver and plasma unbound fraction was determined using equilibrium dialysis. In vivo unbound partitioning (Kp<sub>u,u</sub>) for rosuvastatin, bosentan, and metformin, calculated from total concentrations in the liver and plasma, were 243, 553, and 15, respectively. A physiologically based pharmacokinetic monkey model that incorporates active and passive hepatic uptake was developed to fit plasma and liver concentrations. In addition, a two-compartment model was used to fit in vitro hepatic uptake curves in suspended monkey hepatocyte to determine active uptake, passive diffusion, and intracellular unbound fraction parameters. At steady-state in the model, in vitro Kp<sub>u,u</sub> was determined. The results demonstrated that in vitro values under-predicted in vivo active uptake for rosuvastatin, bosentan, and metformin by 6.7-, 28-, and 1.5-fold, respectively, while passive diffusion was over-predicted. In vivo Kp<sub>u,u</sub> values were under-predicted from in vitro data by 30-, 79-, and 3-fold. In conclusion, active uptake and liver partitioning in monkeys for OATP substrates were greatly under-predicted from in vitro hepatocyte uptake, while OCT-mediated uptake and partitioning scaled reasonably well from in vitro, demonstrating substrate- and transporter-dependent scaling factors. The combination of in vitro experimental and modeling approaches proved useful for assessing prediction of in vivo intracellular partitioning.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Morse</LastName>\n                    <ForeName>Bridget L</ForeName>\n                    <Initials>BL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, NJ, USA.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>MacGuire</LastName>\n                    <ForeName>Jamus G</ForeName>\n                    <Initials>JG</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, NJ, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Marino</LastName>\n                    <ForeName>Anthony M</ForeName>\n                    <Initials>AM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, NJ, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhao</LastName>\n                    <ForeName>Yue</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, NJ, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Fox</LastName>\n                    <ForeName>Maxine</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, NJ, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhang</LastName>\n                    <ForeName>Yueping</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, NJ, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Shen</LastName>\n                    <ForeName>Hong</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, NJ, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Griffith Humphreys</LastName>\n                    <ForeName>W</ForeName>\n                    <Initials>W</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, NJ, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Marathe</LastName>\n                    <ForeName>Punit</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, NJ, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lai</LastName>\n                    <ForeName>Yurong</ForeName>\n                    <Initials>Y</Initials>\n                    <Identifier Source="ORCID">0000-0001-9505-333X</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, NJ, USA. Yurong.lai@gilead.com.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Drug Metabolism, Gilead Sciences Inc., Foster City, California, 94404, USA. Yurong.lai@gilead.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>10</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>AAPS J</MedlineTA>\n            <NlmUniqueID>101223209</NlmUniqueID>\n            <ISSNLinking>1550-7416</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D027361">Organic Anion Transporters</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D027702">Organic Cation Transporter 1</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>83MVU38M7Q</RegistryNumber>\n                <NameOfSubstance UI="D000068718">Rosuvastatin Calcium</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>9100L32L2N</RegistryNumber>\n                <NameOfSubstance UI="D008687">Metformin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>Q326023R30</RegistryNumber>\n                <NameOfSubstance UI="D000077300">Bosentan</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000077300" MajorTopicYN="N">Bosentan</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008252" MajorTopicYN="N">Macaca fascicularis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008687" MajorTopicYN="N">Metformin</DescriptorName>\n                <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D027361" MajorTopicYN="N">Organic Anion Transporters</DescriptorName>\n                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D027702" MajorTopicYN="N">Organic Cation Transporter 1</DescriptorName>\n                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000068718" MajorTopicYN="N">Rosuvastatin Calcium</DescriptorName>\n                <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013449" MajorTopicYN="N">Sulfonamides</DescriptorName>\n                <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">PBPK model</Keyword>\n            <Keyword MajorTopicYN="Y">active hepatic uptake</Keyword>\n            <Keyword MajorTopicYN="Y">drug transporters</Keyword>\n            <Keyword MajorTopicYN="Y">in vitro</Keyword>\n            <Keyword MajorTopicYN="Y">in vivo extrapolation</Keyword>\n            <Keyword MajorTopicYN="Y">unbound tissue partition coefficient</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>06</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>09</Month>\n                <Day>19</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>7</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29019117</ArticleId>\n            <ArticleId IdType="doi">10.1208/s12248-017-0151-z</ArticleId>\n            <ArticleId IdType="pii">10.1208/s12248-017-0151-z</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2013 Nov;41(11):1967-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24009308</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2001 Apr;29(4 Pt 1):453-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11259330</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Xenobiotica. 2007 Aug;37(8):818-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17701831</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2012 Oct;56(10):5381-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22869578</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Pharm. 2015 Dec 7;12 (12 ):4301-10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26528626</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharmacol Exp Ther. 2002 Aug;302(2):510-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12130709</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharmacol Exp Ther. 2009 Feb;328(2):652-62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19001154</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2012 May;40(5):1007-17</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22344703</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Pharmacol. 2007 Jul 15;74(2):359-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17509534</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2011 Oct;39(10):1808-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21730030</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharm Res. 2015 Dec;32(12):3785-802</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26155985</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CPT Pharmacometrics Syst Pharmacol. 2014 Jul 09;3:e124</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25006781</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2014 Oct;42(10):1646-55</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25092714</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetes. 2016 Jun;65(6):1724-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26993065</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharm Sci. 1971 Aug;60(8):1128-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">5127083</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2016 May 23;60(6):3497-508</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27021329</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacol Ther. 1997;73(2):147-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9131722</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Pharmacokinet. 2011 Jun;26(3):220-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21297316</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 1999 Nov;27(11):1350-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10534321</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2017 May;45(5):576-580</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28258068</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2012 Sep;40(9):1744-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22665271</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2015 Nov;43(11):1788-94</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26341276</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2015 Mar;43(3):367-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25534768</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Pharmacol. 2015 Jul;88(1):75-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25920679</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Invest. 2007 May;117(5):1422-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17476361</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharmacol Exp Ther. 2013 Mar;344(3):673-85</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23297161</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Pharmacol Ther. 2016 Nov;100(5):413-418</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27448198</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Pharmacol. 1994 Apr 29;47(9):1469-79</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8185657</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2009 Jul;37(7):1471-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19364828</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharm Sci. 2016 Jun 10;88:70-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27019345</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biopharm Drug Dispos. 2013 Jan;34(1):45-78</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23115084</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharm Sci. 2006 Apr;27(5):425-46</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16488580</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharmacol Exp Ther. 2004 Oct;311(1):139-46</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15159445</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2007 Jun;35(6):859-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17344337</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharm Sci. 2000 Aug;89(8):1008-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10906724</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharmacol Exp Ther. 2012 Apr;341(1):2-15</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22190645</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Pharmacol. 2014 Nov 07;5:240</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25426072</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2013 Nov;41(11):1949-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23990525</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2009 Feb;37(2):386-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19022942</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Pharm. 2010 Jun 7;7(3):630-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20438085</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Drug Discov Devel. 2001 Jan;4(1):36-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11727321</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomed Res Int. 2013;2013:692071</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23984399</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Pharmacol Ther. 2006 May;79(5):427-39</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16678545</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Pharmacol Ther. 2013 Jul;94(1):126-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23588320</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'